Huntington National Bank Blueprint Medicines Corp Transaction History

Huntington National Bank

$15.9 Billion
Q3 2025

A detailed history of Huntington National Bank transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Huntington National Bank holds 1 shares of BPMC stock, worth $129. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 211 99.53%

Holding current value

$129

Previous $27,000 100.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$128.2 - $129.46 $26,921 - $27,186	-210 Reduced 99.53%	1 $0
Q2 2025 Aug 05, 2025	SELL	$79.22 - $128.4 $2,851 - $4,622	-36 Reduced 14.57%	211 $27,000
Q1 2025 May 14, 2025	SELL	$86.69 - $115.63 $4,247 - $5,665	-49 Reduced 16.55%	247 $21,000
Q4 2024 Feb 12, 2025	BUY	$82.48 - $101.39 $5,443 - $6,691	66 Added 28.7%	296 $25,000
Q3 2024 Nov 06, 2024	BUY	$84.1 - $120.5 $4,457 - $6,386	53 Added 29.94%	230 $21,000

Q2 2024 Aug 08, 2024	SELL	$85.18 - $108.78 $9,625 - $12,292	-113 Reduced 38.97%	177 $19,000
Q1 2024 May 03, 2024	BUY	$73.17 - $99.79 $439 - $598	6 Added 2.11%	290 $27,000
Q4 2023 Feb 07, 2024	SELL	$43.96 - $92.84 $3,824 - $8,077	-87 Reduced 23.45%	284 $26,000
Q3 2023 Nov 08, 2023	BUY	$46.9 - $66.0 $5,018 - $7,062	107 Added 40.53%	371 $18,000
Q2 2023 Aug 11, 2023	SELL	$42.2 - $66.37 $464 - $730	-11 Reduced 4.0%	264 $16,000
Q1 2023 May 10, 2023	SELL	$37.97 - $50.0 $379 - $500	-10 Reduced 3.51%	275 $12,000
Q4 2022 Feb 09, 2023	BUY	$41.06 - $66.48 $4,557 - $7,379	111 Added 63.79%	285 $12,000
Q1 2022 May 10, 2022	BUY	$54.1 - $110.08 $649 - $1,320	12 Added 7.41%	174 $11,000
Q4 2021 Jan 21, 2022	SELL	$94.25 - $115.99 $8,388 - $10,323	-89 Reduced 35.46%	162 $17,000
Q3 2021 Oct 28, 2021	SELL	$80.98 - $109.47 $6,316 - $8,538	-78 Reduced 23.71%	251 $26,000
Q2 2021 Jul 30, 2021	BUY	$82.78 - $101.0 $9,271 - $11,312	112 Added 51.61%	329 $29,000
Q1 2021 Apr 12, 2021	BUY	$90.71 - $108.28 $2,086 - $2,490	23 Added 11.86%	217 $21,000
Q4 2020 Jan 11, 2021	SELL	$92.08 - $124.48 $6,906 - $9,336	-75 Reduced 27.88%	194 $22,000
Q3 2020 Oct 30, 2020	BUY	$66.45 - $92.7 $1,129 - $1,575	17 Added 6.75%	269 $25,000
Q2 2020 Jul 30, 2020	BUY	$57.09 - $79.27 $14,386 - $19,976	252 New	252 $20,000

Others Institutions Holding BPMC

# of Institutions

Shares Held

8.58M

Call Options Held

Put Options Held

14.8K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Blueprint Medicines Corp Transaction History